title: Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
abstract: Dystroglycanopathies are a group of congenital muscular dystrophies (CMD) often caused by mutations in genes encoding glycosyltransferases that lead to hypoglycosylation of α-dystroglycan (α-DG) and reduce its extracellular matrix-binding activity. Overexpressing LARGE (formerly known as like-glycosyltransferase) generates an extracellular matrix-binding carbohydrate epitope in cells with CMD-causing mutations in not only LARGE but also other glycosyltransferases, including POMT1, POMGnT1, and fukutin, creating the possibilities of a one-for-all gene therapy. To determine the feasibility of LARGE gene therapy, a serotype 9 adeno-associated viral vector for overexpressing LARGE (AAV9-LARGE) was injected intracardially into newborns of two mouse models of CMD: the natural LARGE mutant Large(myd) mice and protein O-mannose N-acetylglucosaminyltransferase 1 (POMGnT1) knockout mice. AAV9-LARGE virus treatment yielded partial restoration of α-DG glycosylation and ligand-binding activity. The muscular dystrophy phenotype in skeletal muscles was ameliorated as revealed by significantly reduced fibrosis, necrosis, and numbers of centrally located nuclei with improved motor function. These results indicate that LARGE overexpression in vivo by AAV9-mediated gene therapy is effective at restoring functional glycosylation of α-DG and rescuing the muscular dystrophy phenotype in deficiency of not only LARGE but also POMGnT1, providing evidence that in vivo LARGE gene therapy may be broadly useful in dystroglycanopathies.
authors: Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, NY 13210, USA.
authors: Miao
authors: M
authors: Yu
authors: Yonglin
authors: Y
authors: He
authors: Kejian
authors: K
authors: Wang
authors: Peng
authors: P
authors: Zhang
authors: Shengle
authors: S
authors: Zhang
authors: Huaiyu
authors: H
authors: Hu
mesh_terms: D000818:Animals; D000229:Dependovirus / Q000235:genetics*; D004195:Disease Models, Animal; D049030:Dystroglycans / Q000378:metabolism; D005355:Fibrosis / Q000235:genetics / Q000517:prevention & control; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000008:administration & dosage / Q000235:genetics*; D006031:Glycosylation; D051379:Mice; D008822:Mice, Transgenic; D009043:Motor Activity; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D009136:Muscular Dystrophies / Q000235:genetics* / Q000628:therapy*; D017351:N-Acetylglucosaminyltransferases / Q000235:genetics*; D010641:Phenotype; D014161:Transduction, Genetic
chemical_list: D049030:Dystroglycans; C502747:Large1 protein, mouse; D017351:N-Acetylglucosaminyltransferases
references: Nature. 1998 Jul 23;394(6691):388-92
references: 9690476
references: Cell Adhes Commun. 1998 Sep;5(6):475-89
references: 9791728
references: Nat Genet. 2012 May;44(5):575-80
references: 22522420
references: Nat Neurosci. 2008 Aug;11(8):923-31
references: 18641643
references: Biochim Biophys Acta. 2009 Sep;1792(9):853-61
references: 19539754
references: Science. 2010 Jan 1;327(5961):88-92
references: 20044576
references: Hum Mol Genet. 2005 Mar 1;14(5):657-65
references: 15661757
references: Hum Mol Genet. 2009 Feb 15;18(4):621-31
references: 19017726
references: J Med Genet. 2005 Dec;42(12):907-12
references: 15894594
references: Biochim Biophys Acta. 1998 Nov 27;1425(3):599-606
references: 9838223
references: Nature. 2011 Oct 05;478(7367):127-31
references: 21979053
references: Biochem J. 2002 Jan 1;361(Pt 1):153-62
references: 11742540
references: Hum Mol Genet. 2003 Jun 15;12(12):1449-59
references: 12783852
references: Nat Biotechnol. 2009 Jan;27(1):59-65
references: 19098898
references: Biochem Biophys Res Commun. 2002 Mar 15;291(5):1283-6
references: 11883957
references: Gene Ther. 2007 Nov;14(22):1605-9
references: 17898796
references: Glycobiology. 2009 Sep;19(9):971-86
references: 19470663
references: J Cell Biol. 2001 Jul 23;154(2):435-45
references: 11470830
references: Learn Mem. 1998 Sep-Oct;5(4-5):302-16
references: 10454356
references: J Biol Chem. 2010 Oct 8;285(41):31208-16
references: 20682766
references: J Biol Chem. 1993 Jul 15;268(20):14972-80
references: 8325873
references: FASEB J. 2005 Jun;19(8):934-42
references: 15923403
references: J Neurosci Res. 2000 Sep 1;61(5):480-92
references: 10956417
references: J Med Genet. 2004 May;41(5):e61
references: 15121789
references: Mol Ther. 2008 Dec;16(12):1944-52
references: 18827804
references: PLoS One. 2010 Dec 28;5(12):e14434
references: 21203384
references: Hum Mol Genet. 2013 Feb 15;22(4):757-68
references: 23222475
references: FEBS Lett. 1994 Sep 19;352(1):49-53
references: 7925941
references: Hum Mol Genet. 2002 Oct 1;11(21):2673-87
references: 12354792
references: Glycobiology. 2012 Feb;22(2):235-47
references: 21930648
references: Neurology. 2004 Mar 23;62(6):1009-11
references: 15037715
references: J Biol Chem. 2005 May 27;280(21):20851-9
references: 15788414
references: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12109-14
references: 19587235
references: Nature. 2002 Jul 25;418(6896):417-22
references: 12140558
references: Trends Neurosci. 2012 Aug;35(8):487-96
references: 22626542
references: PLoS Genet. 2011 May;7(5):e1002062
references: 21625620
references: Curr Opin Genet Dev. 2011 Jun;21(3):278-85
references: 21397493
references: Neurosci Lett. 2011 Feb 1;489(1):10-5
references: 21129441
references: J Biol Chem. 2006 Jul 14;281(28):19339-45
references: 16698797
references: PLoS One. 2011 Apr 20;6(4):e19080
references: 21533062
references: Nat Med. 2004 Jul;10(7):696-703
references: 15184894
references: Nat Biotechnol. 2005 Mar;23(3):321-8
references: 15735640
references: Science. 2012 Jan 6;335(6064):93-6
references: 22223806
references: Hum Mol Genet. 2001 Dec 1;10(25):2851-9
references: 11741828
references: Curr Opin Neurol. 2011 Oct;24(5):437-42
references: 21825985
references: Mech Dev. 2006 Mar;123(3):228-40
references: 16458488
references: Glycobiology. 2005 Oct;15(10):912-23
references: 15958417
references: Biochem Biophys Res Commun. 2005 Apr 15;329(3):1162-71
references: 15752776
references: Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):500-5
references: 14699049
references: Hum Mol Genet. 2003 Nov 1;12(21):2853-61
references: 12966029
references: Nat Genet. 2001 Jun;28(2):151-4
references: 11381262
references: Nat Med. 2004 Aug;10(8):828-34
references: 15273747
references: J Cell Biol. 1993 Aug;122(4):809-23
references: 8349731
references: Nat Genet. 2012 May;44(5):581-5
references: 22522421
references: J Comp Neurol. 2007 Mar 1;501(1):168-83
references: 17206611
references: Am J Hum Genet. 2002 Nov;71(5):1033-43
references: 12369018
references: Exp Cell Res. 1999 Jan 10;246(1):165-82
references: 9882526
references: J Biol Chem. 1998 Sep 11;273(37):23698-703
references: 9726975
references: Nat Clin Pract Neurol. 2006 Apr;2(4):222-30
references: 16932553
references: Dev Cell. 2001 Nov;1(5):717-24
references: 11709191
references: J Biol Chem. 1997 Jan 24;272(4):2156-62
references: 8999917
references: Cell. 1994 Jun 3;77(5):675-86
references: 8205617